Skip to main content
. 2016 Jan 25;6:20035. doi: 10.1038/srep20035

Figure 4. MSCs reveal reduced motility after cisplatin treatment.

Figure 4

(a) Average velocity of MSCs and differentiated fibroblasts after treatment with 200 and 1000 ng/mL cisplatin. (b) Immunofluorescent actin and microtubule staining in MSCs and fibroblasts after cisplatin treatment (20× objective, scale bar 100 μm). (c) Quantification of actin staining after cisplatin treatment (n ≥ 6). *P < 0.05, ***P < 0.001.